FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
The company said it would apply in coming months for U.S. regulatory approval. Source link
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, paving the way...